Call Us Today: 905-951-3361

Myoguide Upgraded Stimulator Capability!

  December 6, 2016 –Dr. Evan Friedman, President of Intronix Technologies Corporation, announces that this will be effective as of December 15, 2016. Myoguide is a handheld injection guidance device that uses muscle signals (EMG) and stimulation, to help clinicians target the optimal site for injection of therapeutic Botox® type drugs, used for the management of muscle spasms…

Read More

Intronix Technologies to Collaborate with Western University to Develop New Rehabilitation Technologies for Musculoskeletal Disorders

TORONTO, December 15, 2014 – Intronix Technologies will be collaborating with Western University’s Department of Electrical and Computer Engineering to develop technology to be incorporated into rehabilitation devices. Canadian-based innovator, Intronix Technologies, will be working with Dr. Ana Luisa Trejos, Assistant Professor in the Department of Electrical and Computer Engineering at Western University, and Associate…

Read More

Myoguide at AAPM&R meeting in San Diego!

Intronix Technologies’ innovative Myoguide EMG guided injection system will be available to play with at the American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly, November 13–16, 2014 at the San Diego Convention Center. Myoguide is now available throughout Ambu’s worldwide distribution network. You can find Intronix at booth #306 and Ambu USA at…

Read More

Ambu will be distributing Intronix Technologies' Innovative Myoguide System Worldwide

TORONTO, Oct. 27, 2014 /PRNewswire/ — Ambu, a leading global supplier of medical devices, has signed a distribution agreement with Intronix Technologies. Intronix Technologies’ innovative Myoguide EMG guided injection system will be available through Ambu’s worldwide network of distributors, which already services Ambu’s customers locally. The revolutionary Myoguide™ Needle EMG Guided Injection System has breakthrough…

Read More

Intronix Blog

The Intronix Blog is now part of our updated website. We continue to post information as it happens. Follow us and stay informed about all things Myoguide!

Read More

Myoguide Receives an FDA 510(k)

Myoguide receives a US FDA 510(k) K111985. We are preparing to complete the process for FDA clearance and will be launching an E-Commerce section from our website. The E-Commerce system will serve US and Canadian clinicians wishing to order Myoguide directly.

Read More

Information Technology

Myoguide DOC will be coming your way very soon. The goal is to provide anatomically accurate injection site documentation, index tracking, report writing, and electronic medical records.

Read More